----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer |
Belderbos Bodine P.S.I1, De Wit Ronald1, Chien Caly2, Mitselos Anna3, Hellemans Peter3, Jiao James Juhui4, Yu Margaret K.5, Attard Gerhardt6, Bulat Iurie7, Edenfield William Jeffrey8, Saad Fred9 |
1 Erasmus University Medical Center Rotterdam, 4 Janssen Research and Development, Raritan, 7 Institute of Oncology,
|
Cancer Chemotherapy and Pharmacology |
Nr. 3(82) / 2018 / ISSN 0344-5704 |
Disponibil online 4 September, 2018. Descarcări-1. Vizualizări-842 |
----------------------------------------------------------------------------------------------------------------------------------- Vericiguat: a QTc interval study in patients with coronary artery disease |
Boettcher M.-F.1, Duengen H.-D.2, Corcea Vasile3, Donath Frank4, Fuhr Rainard5, Gal Pim6, Mikus Gerd7, Trenk Dietmar8, Werner Nils9, Pires Philippe Vieira10, Maschke Claudia11, Aliprantis Antonios Othon12, Besche Nina13, Becker Corina1 |
1 Clinical Pharmacology, Wuppertal, 2 Berlin School of Public Health, Charité-Universitätsmedizin, Berlin, 3 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 4 SocraTec R and D GmbH, Erfurt, 5 Early Phase Clinical Unit, Berlin, 6 Centre for Human Drug Research, Leiden, 8 University Medical Center Freiburg, 10 Research and Development, Bayer AG, Wuppertal, 11 Study Management, Bayer AG, Wuppertal, 12 Translational Medicine, Merck and Co., Inc., New Jersey , 13 Chrestos Concept GmbH and Co. KG, Essen |
European Heart Journal |
Nr. / 2021 / ISSN 0195-668X |
Disponibil online 30 March, 2024. Descarcări-0. Vizualizări-105 |
----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- Pharmacokinetics, Dialysability, and Safety of Gadopiclenol, a New Gadolinium-Based Contrast Agent, in Patients with Impaired Renal Function |
Bradu Andrei1, Penescu Mircea Nicolae2, Pitrou Camille3, Hao Jing3, Bourrinet Philippe3 |
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 2 University of Medicine and Pharmacy “Carol Davilla”, Bucharest, 3 Guerbet, Roissy CDG Cedex |
Investigative Radiology |
Nr. 8(56) / 2021 / ISSN 0020-9996 /ISSNe 1536-0210 |
Disponibil online 2 August, 2021. Descarcări-0. Vizualizări-513 |
----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-8 of 8